SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Frontiers in Anti-Infective Drug Discovery
View SampleDownload Sample

Editors: Atta-ur-Rahman , M. Iqbal Choudhary

Frontiers in Anti-Infective Drug Discovery

Volume 4
eBook: US $109 Special Offer (PDF + Printed Copy): US $199
Printed Copy: US $144
Library License: US $436
ISSN: 2451-9162 (Print)
ISSN: 1879-663X (Online)
ISBN: 978-1-68108-083-3 (Print)
ISBN: 978-1-68108-082-6 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810808261150401
Rate This Book

Introduction

This eBook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the eBook series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.

Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.

The fourth volume of this series features 5 chapters that cover the following topics:

  • - An overview of the incidence of neuraminadase resistance in influenza viruses in the Americas from 2004 to 2014
  • - Phenothiazines and derivative compounds for treating Trypanosoma cruzi infections
  • - New antibacterial drug targets such as polysaccharide deacetylases
  • - Improvements in aminoglycoside synthesis and biological activity (including RNA targeting)
  • - A review of new chemotherapeutic agents against common infections.

Indexed in: Book Citation Index, Science Edition, BIOSIS Previews, Scopus, EMBASE, EBSCO, Ulrich's Periodicals Directory.


eBook: US $109 Special Offer: US $199 Printed Copy: US $144 Library License: US $436

Contributors

Editor(s):
Atta-ur-Rahman
University of Cambridge
Kings College
Cambridge
UK


M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi, 75270
Pakistan



Contributor(s):
Agatha Bastida
Institute of General Organic Chemistry of the Spanish National Research Council
Bioorganic Chemistry Department
Juan de la Cierva, 3, 28006-Madrid
Spain


Ana García-Robles
Pharmacy Department
Hospital Universitari i Politècnic La Fe
Valencia
Spain


Andrés G. Santana
Institute of General Organic Chemistry of the Spanish National Research Council
Bioorganic Chemistry Department
Juan de la Cierva, 3, 28006-Madrid
Spain


Dimitris Koutsioulis
Department of Biology, Enzyme Biotechnology Group
University of Crete
P.O. Box 2208, Vasilika Vouton
Heraklion
Crete, 714 09
Greece


Eva Romá-Sánchez
Pharmacy Department
Hospital Universitari i Politècnic La Fe
Valencia
Spain


J.N.S.S. Couceiro
Institute of Microbiology Paulo de Góes
Federal University of Rio de Janeiro
Rio de Janeiro
RJ, 21941-902
Brazil


José Luis Poveda-Andrés
Pharmacy Department
Hospital Universitari i Politècnic La Fe
Valencia
Spain


Julia Revuelta
Institute of General Organic Chemistry of the Spanish National Research Council
Bioorganic Chemistry Department
Juan de la Cierva, 3, 28006-Madrid
Spain


L.A.M.G. Fornells
Institute of Microbiology Paulo de Góes
Federal University of Rio de Janeiro
Rio de Janeiro
RJ, 21941-902
Brazil


Patricia Paglini Oliva
Medical Biophysics, Faculty of Medicine and INICSA
CONICET, National University of Córdoba
Santa Rosa
Córdoba, 1085
Argentina


Sandra G. Zárate
Institute of General Organic Chemistry of the Spanish National Research Council
Bioorganic Chemistry Department
Juan de la Cierva, 3, 28006-Madrid
Spain


Silvina Lo Presti
Medical Biophysics, Faculty of Medicine and INICSA
CONICET, National University of Córdoba
Santa Rosa
Córdoba, 1085
Argentina


Sofia Arnaouteli
Department of Biology, Enzyme Biotechnology Group
University of Crete
P.O. Box 2208, Vasilika Vouton
Heraklion
Crete, 714 09
Greece


Stavroula Balomenou
Institute of Molecular Biology and Biotechnology
Heraklion
Crete, 70013
Greece
/
Department of Biology, Enzyme Biotechnology Group
University of Crete
P.O. Box 2208, Vasilika Vouton
Heraklion
Crete, 714 09
Greece


Vasiliki E. Fadouloglou
Institute of Molecular Biology and Biotechnology
Heraklion
Crete, 70013
Greece


Vassilis Bouriotis
Institute of Molecular Biology and Biotechnology
Heraklion
Crete, 70013
Greece
/
Department of Biology, Enzyme Biotechnology Group
University of Crete
P.O. Box 2208, Vasilika Vouton
Heraklion
Crete, 714 09
Greece


Virginia Bosó-Ribelles
Pharmacy Department
Hospital Universitari i Politècnic La Fe
Valencia
Spain


Walter Rivarola
Medical Biophysics, Faculty of Medicine and INICSA, CONICET
National University of Córdoba
Córdoba
Santa Rosa, 1085
Argentina



RELATED BOOKS

.Vector Borne Diseases: Current Trends and Public Health Perspectives.
.Concise Handbook of Epidemiology.
.Frontiers in Clinical Drug Research - Anti Infectives- Vol 9.
.COVID-19: Causes, Transmission, Diagnosis, and Treatment.